Institute for Research in Fundamental Sciences
Tehran, Iran
Location status: Recruiting
NCT Number: NCT06974136
This project investigates the efficacy of transcranial electrical stimulation (tES) modalities, specifically transcranial direct current stimulation (tDCS) and transcranial alternating current stimulation (tACS), for treating Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents.
Interested in participating?
Request Info7 year–18 year
All sexes
Interventional
Not applicable
Tehran, Iran
Location status: Recruiting
This project aims to evaluate the therapeutic potential of transcranial electrical stimulation (tES) modalities, specifically transcranial direct current stimulation (tDCS) and transcranial alternating current stimulation (tACS), as innovative, non-invasive interventions for managing Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents. ADHD is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity that impair daily functioning. Conventional treatments, such as pharmacological interventions and behavioral therapies, may have limitations, including side effects or variable efficacy, prompting the exploration of neuromodulation techniques like tES.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Transcranial electrical stimulation (tES) is a non-invasive neuromodulation technique that applies low-intensity electrical currents to the scalp to modulate brain activity. It targets specific brain regions to influence neuronal excitability, connectivity, and plasticity, offering potential therapeutic benefits for neurological and psychiatric conditions. tES is portable, cost-effective, and generally well-tolerated, with minimal side effects such as mild tingling or itching at the stimulation site.
Other names: tDCS, tACS
Time frame: Baseline, week 2, up to 1 month after the intervention
ADHD symptoms will be assessed using a DSM-based structured interview. This approach involves a systematic, standardized method to evaluate the presence and severity of ADHD symptoms based on the diagnostic criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders (DSM), likely the DSM-5, which is widely used for diagnosing ADHD.
Time frame: Baseline, week 2, up to 1 month after the intervention
Performance in an executive functions computerized task
Time frame: Baseline, week 2
Change in the EEG alpha/theta/gamma power
Time frame: Baseline, week 2
Contact information is provided by the study sponsor or research team.
The National Brain Mapping Laboratory (NBML)
Other
Transcranial Electrical Stimulation Modalities for the Treatment of Clinical Symptoms and Cognitive Deficits in Attention-deficit Hyperactivity Disorder Disorder
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01721720
Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity
Bethesda, Maryland, United States
View Trial DetailsNCT05875363
Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity
Taipei, Taiwan
View Trial DetailsNCT00104039
Antisocial Personality Disorder, Attention Deficit Disorder With Hyperactivity
Bethesda, Maryland, United States
View Trial DetailsNCT01940978
ADHD, Attention Deficit Disorder With Hyperactivity
Van Nuys, California, United States
View Trial Details